Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Grace Therapeutics, Inc GRCE

Grace Therapeutics, Inc., formerly Acasti Pharma Inc., is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Its therapeutic pipeline consists of three clinical-stage drug candidates supported by an intellectual property portfolio of over 40 granted and pending patents in various jurisdictions. Its lead drug candidate, GTX-104, is a clinical-stage, novel, injectable formulation of nimodipine being developed for intravenous (IV) infusion in aneurysmal subarachnoid hemorrhage (aSAH) patients to address significant unmet medical needs. GTX-104 provides a convenient IV delivery of nimodipine in the intensive care unit, eliminating the need for nasogastric tube administration in unconscious or dysphagic patients. Its other pipeline drug candidates include GTX-102, which is an oral-mucosal betamethasone spray for the treatment of Ataxia Telangiectasia and GTX-101, which is a topical bio adhesive film-forming bupivacaine spray for Postherpetic Neuralgia.


NDAQ:GRCE - Post by User

User Avatar Image
(52)
•••
  • Francine01X
Comment by Francine01on Aug 31, 2021 11:24am
224 Views
Post# 33787793

RE:RE:RE:RE:Successful Completion of its Merger with Grace Therapeutics

RE:RE:RE:RE:Successful Completion of its Merger with Grace TherapeuticsI sold my position during the 1.20US/1.50Cdn rally. Now buying at the equivalent of 34 cents is very compelling. I bought a small position this morning and will average down. 

For Janelle, we need to presume that the stock will tank today and she will attribute a few millions stock options this week .. This was her game since the beggining, she never put a single dollar in the company. 

Like I said a thousand time, she should be in jail for the November 2017 non binding China deal. .. 

GLTA 
<< Previous
Bullboard Posts
Next >>